Equillium (EQ) Shares Surge 2.9% as Market Capitalization Hits $90 M in Latest Update
Equillium shares rise 2.9% as market cap hits $90m; 2026-27 results and FDA update on Unicycive’s kidney drug highlight biotech gains.
2 minutes to read
EQUILLIUM INC
Equillium (EQ) Rallies 2.9% Yet Faces 26% Decline, Weak Fundamentals, and Uncertain Future
Equillium (EQ) sees a 2.9 % rally but its 26 % monthly decline signals fragile fundamentals; investors need clear clinical wins, partnerships, and stronger governance to sustain growth.
3 minutes to read